Statistics

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	18

	Downloads
6807-30551.pdf	64

Select a period of time:

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	5

	Downloads
6807-30551.pdf	8

	Views
United States	3
United Kingdom	2

	Downloads
United States	6

	Views
Chicago	3

	Downloads
Chicago	1

RUNA digital repository